Premier, Inc. (PINC)
USD 19.32
(0.36%)
USD 19.32
(0.36%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 1.46 Billion USD | 38.77% |
| 2023 | 1.03 Billion USD | -6.42% |
| 2022 | 1.1 Billion USD | -14.29% |
| 2021 | 1.29 Billion USD | -53.97% |
| 2020 | 2.8 Billion USD | -18.14% |
| 2019 | 3.43 Billion USD | -8.22% |
| 2018 | 3.73 Billion USD | -10.33% |
| 2017 | 4.17 Billion USD | 9.54% |
| 2016 | 3.8 Billion USD | -18.1% |
| 2015 | 4.64 Billion USD | 25.06% |
| 2014 | 3.71 Billion USD | 613.23% |
| 2013 | 521.14 Million USD | 9.37% |
| 2012 | 476.5 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 1.44 Billion USD | -0.13% |
| 2024 Q4 | 1.46 Billion USD | 1.8% |
| 2024 Q2 | 1.44 Billion USD | -3.64% |
| 2024 FY | 1.46 Billion USD | 41.39% |
| 2024 Q1 | 1.49 Billion USD | 44.33% |
| 2023 Q1 | 1.15 Billion USD | 4.52% |
| 2023 FY | 1.03 Billion USD | -6.42% |
| 2023 Q3 | 1.17 Billion USD | -4.59% |
| 2023 Q4 | 1.03 Billion USD | -11.86% |
| 2023 Q2 | 1.23 Billion USD | 6.47% |
| 2022 Q2 | 1.17 Billion USD | -5.34% |
| 2022 Q4 | 1.1 Billion USD | -13.54% |
| 2022 FY | 1.1 Billion USD | -14.29% |
| 2022 Q1 | 1.23 Billion USD | -4.19% |
| 2022 Q3 | 1.28 Billion USD | 9.31% |
| 2021 Q1 | 1.3 Billion USD | -53.48% |
| 2021 FY | 1.29 Billion USD | -53.97% |
| 2021 Q4 | 1.29 Billion USD | -11.88% |
| 2021 Q3 | 1.46 Billion USD | 9.64% |
| 2021 Q2 | 1.33 Billion USD | 2.4% |
| 2020 Q4 | 2.8 Billion USD | -3.85% |
| 2020 Q3 | 2.92 Billion USD | -4.18% |
| 2020 Q2 | 3.04 Billion USD | 12.53% |
| 2020 FY | 2.8 Billion USD | -18.14% |
| 2020 Q1 | 2.7 Billion USD | -21.05% |
| 2019 Q2 | 3.53 Billion USD | -20.95% |
| 2019 FY | 3.43 Billion USD | -8.22% |
| 2019 Q4 | 3.43 Billion USD | 4.44% |
| 2019 Q1 | 4.47 Billion USD | 19.61% |
| 2019 Q3 | 3.28 Billion USD | -7.06% |
| 2018 Q3 | 3.42 Billion USD | 4.9% |
| 2018 Q2 | 3.26 Billion USD | -13.79% |
| 2018 Q1 | 3.79 Billion USD | -9.05% |
| 2018 FY | 3.73 Billion USD | -10.33% |
| 2018 Q4 | 3.73 Billion USD | 9.02% |
| 2017 Q2 | 3.99 Billion USD | 7.15% |
| 2017 FY | 4.17 Billion USD | 9.54% |
| 2017 Q3 | 4.04 Billion USD | 1.09% |
| 2017 Q1 | 3.73 Billion USD | -2.01% |
| 2017 Q4 | 4.17 Billion USD | 3.2% |
| 2016 Q1 | 4.32 Billion USD | -7.03% |
| 2016 Q2 | 4.23 Billion USD | -2.02% |
| 2016 Q4 | 3.8 Billion USD | -2.95% |
| 2016 FY | 3.8 Billion USD | -18.1% |
| 2016 Q3 | 3.92 Billion USD | -7.36% |
| 2015 Q3 | 4.54 Billion USD | 10.35% |
| 2015 FY | 4.64 Billion USD | 25.06% |
| 2015 Q2 | 4.12 Billion USD | 0.04% |
| 2015 Q4 | 4.64 Billion USD | 2.21% |
| 2015 Q1 | 4.11 Billion USD | 10.83% |
| 2014 Q1 | 444.92 Million USD | -14.63% |
| 2014 Q3 | 4.14 Billion USD | -9.46% |
| 2014 FY | 3.71 Billion USD | 613.23% |
| 2014 Q4 | 3.71 Billion USD | -10.37% |
| 2014 Q2 | 4.58 Billion USD | 929.42% |
| 2013 Q4 | 521.14 Million USD | 26.86% |
| 2013 Q3 | 410.8 Million USD | 0.0% |
| 2013 FY | 521.14 Million USD | 9.37% |
| 2012 FY | 476.5 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Ontrak, Inc. | 5.57 Million USD | -26202.493% |
| iCoreConnect Inc. | 11.24 Million USD | -12943.232% |
| Augmedix, Inc. | 43.39 Million USD | -3279.42% |
| BrightSpring Health Services, Inc. Common Stock | 5.17 Billion USD | 71.681% |
| CareCloud, Inc. | 37.79 Million USD | -3779.578% |
| CareCloud, Inc. | 37.79 Million USD | -3779.578% |
| HealthEquity, Inc. | 1.2 Billion USD | -22.047% |
| Inovalon Holdings, Inc. | 1.26 Billion USD | -16.131% |
| Nutex Health, Inc. | 319.13 Million USD | -359.474% |
| OneMedNet Corporation | 13.32 Million USD | -10906.538% |
| Progyny, Inc. | 203.19 Million USD | -621.668% |
| Omnicell, Inc. | 1.03 Billion USD | -41.279% |
| Renalytix Plc | 15.82 Million USD | -9165.538% |
| Schrödinger, Inc. | 254.39 Million USD | -476.408% |
| Simulations Plus, Inc. | 14.2 Million USD | -10220.693% |
| SOPHiA GENETICS SA | 54.71 Million USD | -2580.053% |
| Streamline Health Solutions, Inc. | 22.92 Million USD | -6296.074% |
| Minerva Surgical, Inc. | 51.71 Million USD | -2735.252% |
| GE HealthCare Technologies Inc. | 25.14 Billion USD | 94.168% |
| Sharecare, Inc. | 125.56 Million USD | -1067.813% |
| Aclarion, Inc. | 3.18 Million USD | -45899.694% |
| CareMax, Inc. | 561.85 Million USD | -160.985% |
| Bullfrog AI Holdings, Inc. Common Stock | 184.35 Thousand USD | -795323.922% |
| Forian Inc. | 33.19 Million USD | -4317.242% |
| Bullfrog AI Holdings, Inc. Warrants | 184.35 Thousand USD | -795323.922% |
| HeartBeam, Inc. | 1.19 Million USD | -122711.055% |
| GeneDx Holdings Corp. | 245.65 Million USD | -496.915% |
| SCWorx Corp. | 2.42 Million USD | -60374.454% |
| Definitive Healthcare Corp. | 626.72 Million USD | -133.972% |
| 10x Genomics, Inc. | 224.1 Million USD | -554.335% |
| Zhongchao Inc. | 3.37 Million USD | -43303.159% |
| Accolade, Inc. | 342.68 Million USD | -327.903% |
| MSP Recovery, Inc. | 1.74 Billion USD | 15.768% |
| R1 RCM Inc. | 2.2 Billion USD | 33.613% |
| Spok Holdings, Inc. | 63.91 Million USD | -2194.313% |
| Privia Health Group, Inc. | 392.51 Million USD | -273.585% |
| EUDA Health Holdings Limited | 8.79 Million USD | -16577.547% |
| TruBridge, Inc. | 247.8 Million USD | -491.743% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 5.17 Billion USD | 71.681% |
| Sharecare, Inc. | 125.56 Million USD | -1067.813% |
| Health Catalyst, Inc. | 334.89 Million USD | -337.858% |
| GoodRx Holdings, Inc. | 826.84 Million USD | -77.345% |
| HealthStream, Inc. | 159.19 Million USD | -821.141% |
| Certara, Inc. | 516.29 Million USD | -184.014% |
| GeneDx Holdings Corp. | 245.65 Million USD | -496.915% |
| Ontrak, Inc. | 5.57 Million USD | -26202.493% |
| SHL Telemedicine Ltd. | 36.58 Million USD | -3907.749% |
| CareCloud, Inc. | 37.79 Million USD | -3779.578% |
| EUDA Health Holdings Limited | 8.79 Million USD | -16577.547% |
| HeartBeam, Inc. | 1.19 Million USD | -122711.055% |
| Mangoceuticals, Inc. | 276.03 Thousand USD | -531116.241% |
| CareMax, Inc. | 561.85 Million USD | -160.985% |
| Healthcare Triangle, Inc. | 9.51 Million USD | -15317.559% |
| National Research Corporation | 73.48 Million USD | -1895.542% |
| Aclarion, Inc. | 3.18 Million USD | -45899.694% |
| OptimizeRx Corporation | 56.82 Million USD | -2480.685% |